Menu
← Oncology Approval Tracker
FDA DECISION ·
Xeloda + docetaxel
capecitabine plus docetaxel · Genentech
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Combination with docetaxel for advanced or metastatic breast cancer progressing after an anthracycline-containing regimen.
LAMPGEN ANALYSIS
Why it matters
The revised combination indication specifies progression after anthracycline exposure.
What research teams should watch
Reconcile prior treatment and progression date, and track the separate administration schedules of both drugs.
PRIMARY RECORDS